近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Zheng Y, Wang M, Li S, Bu Y, Xu Z, Zhu G, Wu C, Zhao K, Li A, Chen Q, Wang J, Hua R, Teng Y, Zhao L, Cheng X, Xia Y*.
Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies.
PLoS Pathogens. 2023 May 24;19(5):e1011382.
2. Yi J, Lei X, Guo F, Chen Q, Chen X, Zhao K, Zhu C, Cheng X, Lin J*, Yin H*, Xia Y*.
Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models.
Antiviral Research. 2023 Jul;215:105618.
3. Li A, Zhang B, Zhao K, Yin Z, Teng Y, Zhang L, Xu Z, Liang K, Cheng X*, Xia Y*.
SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
Journal of Virology. 2023 Jun 22:e0051223.
4. Zhao K, Guo F, Wang J, Zhong Y, Yi J, Teng Y, Xu Z, Zhao L, Li A, Wang Z, Chen X, Cheng X, Xia Y*.
Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells.
Hepatology. 2023 Apr 1;77(4):1366-1381.
5. Zhong Y, Wu C, Xu Z, Teng Y, Zhao L, Zhao K, Wang J, Wang W, Zhan Q, Zhu C, Chen X, Liang K, Cheng X, Xia Y*.
Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
Journal of Virology. 2022 Nov 9;96(21):e0136222.
6. Xu Z, Zhao L, Zhong Y, Zhu C, Zhao K, Teng Y, Cheng X, Chen Q, Xia Y*.
A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
Cell Mol Gastroenterol Hepatol. 2022;13(4):1001-1017.
7. Teng Y, Xu Z, Zhao K, Zhong Y, Wang J, Zhao L, Zheng Z, Hou W, Zhu C, Chen X, Protzer U, Li Y*, Xia Y*.
Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection.
Journal of Hepatology. 2021 Nov;75(5):1072-1082.
8. Li A, Zhao K, Zhang B, Hua R, Fang Y, Jiang W, Zhang J, Hui L, Zheng Y, Li Y, Zhu C, Wang PH, Peng K, Xia Y*.
SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist.
Journal of Virology. 2021 Aug 10;95(17):e0074721. doi: 10.1128/JVI.00747-21.
9. Liu R, Zhao L, Cheng X, Huan H, Li C, Li D, Liu A, Gao G, Zhou F, Liu F, Jiang Y*, Zhu C*, Xia Y*.
Clinical Characteristics of COVID-19 Patients with Hepatitis B Virus Infection - a Retrospective Study.
Liver International. 2021 Apr;41(4):720-730. doi: 10.1111/liv.14774.(封面文章，ESI高被引)
10. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C*, Xia Y*. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Emerging Microbes & Infection. 2020 Dec;9(1):1123-1130.（ESI高被引）
11. Xia Y, Liang TJ. Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of HBV Infection.
Gastroenterology. 2019 Jan;156(2):311-324.（ESI高被引）
12. Xia Y, Carpentier A, Cheng X, Block PD, Zhao Y, Zhang Z, Protzer U, Liang TJ. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
Journal of Hepatology. 2017 Mar;66(3):494-503.
13. Xia Y#, Stadler D#, Lucifora J, Reisinger F, Webb D, Hösel M, Michler T, Wisskirchen K, Cheng X, Zhang K, Chou WM, Wettengel JM, Malo A, Bohne F, Hoffmann D, Eyer F, Thimme R, Falk CS, Thasler WE, Heikenwalder M, Protzer U.
Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
Gastroenterology. 2016 Jan;150(1):194-205.（ESI高被引）
14. Lucifora J#, Xia Y#, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T, Remouchamps C, Chou WM, Thasler WE, Hüser N, Durantel D, Liang TJ, Münk C, Heim MH, Browning JL, Dejardin E, Dandri M, Schindler M, Heikenwalder M, Protzer U.
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
Science. 2014 Mar 14;343(6176):1221-8.（ESI高被引）
京公网安备 11010802027423号